Literature DB >> 27225756

An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes.

Blaine Phillips, Emilija Veljkovic, Stéphanie Boué, Walter K Schlage, Gregory Vuillaume, Florian Martin, Bjoern Titz, Patrice Leroy, Ansgar Buettner, Ashraf Elamin, Alberto Oviedo, Maciej Cabanski, Héctor De León, Emmanuel Guedj, Thomas Schneider, Marja Talikka, Nikolai V Ivanov, Patrick Vanscheeuwijck, Manuel C Peitsch, Julia Hoeng.   

Abstract

Entities:  

Year:  2016        PMID: 27225756      PMCID: PMC7297302          DOI: 10.1093/toxsci/kfw062

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


× No keyword cloud information.
doi: 10.1093/toxsci/kfv243 Toxicological Sciences 149(2),411–432, 2016 Upon further review of Supplementary Table 1, the authors identified that some data were erroneously swapped when reporting. The corrected table is available online. This error has no impact on the overall validity or conclusion of the study. The authors regret this error. Supplementary Table 1. Yields per cigarette of selected 3R4F mainstream smoke and THS aerosol constituents (HPHCs). A. Normalized for nicotine levels, analysis from a THS2.2 batch used in this study (3R4F was measured in a previous study but is considered representative of the actual batches used during this study). B. Total weights per chemical classes, manufacturer’s specifications. *Measurement replaced by lower limit of quantification. Remarks: Smoke/aerosol generation according to Health Canada regimen (Burnset al., 2008). These numbers are provided to illustrate the reduction in HPHCs per chemical class and were derived from later product batches.

A. Normalized for nicotine levels, analysis from a THS2.2 batch used in this study (3R4F was measured in a previous study but is considered representative of the actual batches used during this study).

ISO parameters THS2.2 3R4F
1. Carbon monoxidemg/mg nicotine0.437 ± 0.03114.8 ± 0.715
2. Nicotinemg/mg nicotine1 ± 0.0451 ± 0.0542
3. Tarmg/mg nicotine6.304 ± 1.21414.3 ± 0.717
4. TPMmg/mg nicotine34.72 ± 1.39622.2 ± 1.2
5. Watermg/mg nicotine27.41 ± 1.9377.01 ± 0.673
Aliphatic dienes
6. 1,3-Butadieneµg/mg nicotine0.298 ± 0.05336.7 ± 3.6
7. Isopreneµg/mg nicotine2.483 ± 0.335427 ± 36.4
Carbonyls
8. Acetaldehydeµg/mg nicotine157.9 ± 15.78719 ± 50.1
9. Acetoneµg/mg nicotine29.35 ± 3.463323 ± 11.9
10. Acroleinµg/mg nicotine8.165 ± 1.18977 ± 5.51
11. Butyraldehydeµg/mg nicotine20.32 ± 2.02441.7 ± 3.64
12. Crotonaldehydeµg/mg nicotine2.809 ± 0.33340.5 ± 4.31
13. Formaldehydeµg/mg nicotine2.623 ± 0.27128.3 ± 3.48
14. Methyl ethyl ketoneµg/mg nicotine5.986 ± 0.9191.9 ± 5.79
15. Propionaldehydeµg/mg nicotine11.75 ± 1.48358.1 ± 2.68
Acid derivatives
16. Acetamideµg/mg nicotine3.063 ± 0.2837.17 ± 0.399
17. Acrylamideµg/mg nicotine1.918 ± 0.1882.03 ± 0.157
18. Acrylonitrileµg/mg nicotine0.166 ± 0.01314.4 ± 0.894
Epoxides
19. Ethylene oxideµg/mg nicotine0.167 ± 0.01112.9 ± 0.998
20. Propylene oxideµg/mg nicotine0.094 ± 0.0080.723 ± 0.0234
Nitro compounds
21. NitrobenzeneN.D.N.D.
Aromatic Amines
22. 1-Aminonaphthaleneng/mg nicotine0.065 ± 0.0079.95 ± 0.6
23. 2-Aminonaphthaleneng/mg nicotine3/4 < 0.0245.11 ± 0.186
24. 3-Aminobiphenylng/mg nicotine0.043 ± 0.0051.64 ± 0.213
25. 4-Aminobiphenylng/mg nicotine4/4 < 0.0321.31 ± 0.115
26. o-Toluidineng/mg nicotine0.962 ± 0.07643.5 ± 1.45
27. Benzidineng/mg nicotine4/4 < 7E-4N.D.
N-Heterocyclic aromatics
28. Pyridineµg/mg nicotine6.343 ± 0.28318 ± 0.833
29. Quinolineµg/mg nicotine0.016 ± 0.0010.273 ± 0.0276
Halogen compounds
30. Vinyl chlorideng/mg nicotine4/4 < 2.47750.2 ± 2.75
Inorganic compounds
31. Ammoniaµg/mg nicotine10.18 ± 0.61119.4 ± 0.847
32. Hydrogen cyanideµg/mg nicotine2.905 ± 0.201215 ± 17.2
33. Nitric oxideµg/mg nicotine11.37 ± 0.521218 ± 10.3
34. Nitrogen oxidesµg/mg nicotine11.48 ± 0.516240 ± 12.3
Monocyclic aromatics
35. Benzeneµg/mg nicotine0.538 ± 0.03746.8 ± 1.7
36. Styreneµg/mg nicotine0.578 ± 0.04811.9 ± 0.497
37. Tolueneµg/mg nicotine2.172 ± 0.23197.8 ± 3.8
N-nitrosamines
38. N-Nitrosoanabasine (NAB)ng/mg nicotine4/4 < 2.17318 ± 1.24
39. N-Nitrosoanatabine (NAT)ng/mg nicotine11.67 ± 1.224173 ± 10.1
40. 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK)ng/mg nicotine4.631 ± 0.387117 ± 5.56
41. N-Nitrosonornicotine (NNN)ng/mg nicotine10.37 ± 1.039155 ± 4.31
Phenols
42. Catecholµg/mg nicotine15.53 ± 1.69843.8 ± 2.17
43. m+p-cresolµg/mg nicotine0.123 ± 0.026.04 ± 0.448
44. o-cresolµg/mg nicotine0.102 ± 0.0142.08 ± 0.18
45. Hydroquinoneµg/mg nicotine6.614 ± 0.85940.2 ± 1.85
46. Phenolµg/mg nicotine1.617 ± 0.2696.59 ± 0.497
47. Resorcinolµg/mg nicotine0.049 ± 0.0040.894 ± 0.0364
PAHs
48. Benzo[a]pyreneng/mg nicotine3/4 < 0.6964.66 ± 1.87
49. Benz[a]anthraceneng/mg nicotine1.078 ± 0.0519.21 ± 3.19
50. Dibenz[a,h]anthraceneng/mg nicotine4/4 < 0.073/8 < 0
51. Pyreneng/mg nicotine4.085 ± 0.2425.5 ± 15.2
Metals/Elements
52. Arsenicng/mg nicotine3/3 < 0.7873.32 ± 0.209
53. Cadmiumng/mg nicotine0.371 ± 0.00863.7 ± 3.28
54. Chromiumng/mg nicotine3/3 < 0.1184/4 < 0.257
55. Leadng/mg nicotine3/3 < 2.33214.8 ± 0.773
56. Mercuryng/mg nicotine1.024 ± 0.1051.86 ± 0.0981
57. Nickelng/mg nicotine2/3 < 0.1184/4 < 0.257
58. Seleniumng/mg nicotine3/3 < 0.3830.687 ± 0.126

B. Total weights per chemical classes, manufacturer’s specifications.

Chemical classUnit weight per stickTotal weight% reduction
3R4FTHS2.2
Carbon monoxidemg32.80.53198.4%
Carbonylsµg2970.7328.4588.9%
Nitrogen oxidesµg102834.196.7%
Aliphatic dienesµg861.82.64499.7%
Inorganic compoundsµg532.319.0196.4%
Monocyclic aromatic HCµg310.13.84798.8%
Phenolsµg206.6225.77187.5%
Acid derivativesµg50.636.00888.1%
N-Heterocyclic aromaticsµg36.6137.55279.4%
Epoxidesµg30.720.34998.9%
TSNAng926.747.52*94.9%
Elementsng214.037.65*96.4%
PAHsng131.27.55*94.2%
Aromatic aminesng124.331.466*98.8%
Halogen compoundsng96.73.54*96.3%
Nitro compoundsng0.4990.0982.0%

*Measurement replaced by lower limit of quantification.

Remarks: Smoke/aerosol generation according to Health Canada regimen (Burnset al., 2008). These numbers are provided to illustrate the reduction in HPHCs per chemical class and were derived from later product batches.

  6 in total

1.  Impact of switching to a heat-not-burn tobacco product on CYP1A2 activity.

Authors:  Angela van der Plas; Sandrine Pouly; Nicolas Blanc; Christelle Haziza; Guillaume de La Bourdonnaye; Bjorn Titz; Julia Hoeng; Nikolai V Ivanov; Brindusa Taranu; Annie Heremans
Journal:  Toxicol Rep       Date:  2020-10-29

2.  The sbv IMPROVER Systems Toxicology Computational Challenge: Identification of Human and Species-Independent Blood Response Markers as Predictors of Smoking Exposure and Cessation Status.

Authors:  Vincenzo Belcastro; Carine Poussin; Yang Xiang; Maurizio Giordano; Kumar Parijat Tripathi; Akash Boda; Stéphanie Boué; Mario Guarracino; Florian Martin; Manuel C Peitsch; Julia Hoeng; Roberto Romero; Adi L Tarca; Zhongqu Duan; Hao Yang; Xiaofeng Gong; Peixuan Wang; Chenfang Zhang; Wenxin Yang; Omer Sinan Sarac; Ismail Bilgen; Ali Tugrul Balci; Rahul Kumar; Sandeep Kumar Dhanda
Journal:  Comput Toxicol       Date:  2017-07-14

3.  In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke.

Authors:  Linsey E Haswell; Sarah Corke; Ivan Verrastro; Andrew Baxter; Anisha Banerjee; Jason Adamson; Tomasz Jaunky; Christopher Proctor; Marianna Gaça; Emmanuel Minet
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

4.  E-vapor aerosols do not compromise bone integrity relative to cigarette smoke after 6-month inhalation in an ApoE-/- mouse model.

Authors:  Marie K Reumann; Jenny Schaefer; Bjoern Titz; Romina H Aspera-Werz; Ee Tsin Wong; Justyna Szostak; Victor Häussling; Sabrina Ehnert; Patrice Leroy; Wei Teck Tan; Arkadiusz Kuczaj; Christof Audretsch; Fabian Springer; Andreas Badke; Peter Augat; Leticia Quentanilla-Fend; Manuela Martella; K Monica Lee; Manuel C Peitsch; Julia Hoeng; Andreas K Nussler
Journal:  Arch Toxicol       Date:  2020-05-14       Impact factor: 5.153

Review 5.  Nicotine in Senescence and Atherosclerosis.

Authors:  Ann Marie Centner; Pradeep G Bhide; Gloria Salazar
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

6.  Systems toxicology study reveals reduced impact of heated tobacco product aerosol extract relative to cigarette smoke on premature aging and exacerbation effects in aged aortic cells in vitro.

Authors:  Carine Poussin; Marco van der Toorn; Sophie Scheuner; Romain Piault; Athanasios Kondylis; Rebecca Savioz; Rémi Dulize; Dariusz Peric; Emmanuel Guedj; Fabio Maranzano; Celine Merg; Moran Morelli; Anne-Laure Egesipe; Stéphanie Johne; Shoaib Majeed; Claudius Pak; Thomas Schneider; Walter K Schlage; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Arch Toxicol       Date:  2021-07-27       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.